MASIMO CORPORATION (NASDAQ:MASI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02….Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Report on Form 8-K is hereby incorporated by reference into this
Item 5.02.
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
Stockholders on June 1, 2017>(the Meeting). At the Meeting, a
total of 46,435,240 shares, or 90.79% of the Companys common
stock issued and outstanding as of the record date, were
represented in person or by proxy.
proposals, each of which is described in more detail in the
Companys definitive proxy statement filed with the Securities and
Exchange Commission (SEC) on April 11, 2017, as supplemented by
the supplements thereto filed with the SEC on May 24, 2017 and
May 26, 2017.
at the Meeting and the voting results with respect to each
matter.
directors to serve until the Companys 2020 Annual Meeting of
Stockholders.
Nominee
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
Dr. Steven J. Barker
|
40,324,787
|
1,712,812
|
16,315
|
4,381,326
|
Sanford Fitch
|
41,668,707
|
367,547
|
17,660
|
4,381,326
|
as the Companys independent registered public accounting firm for
the Companys fiscal year ending December 30, 2017.
For
|
Against
|
Abstentions
|
46,229,974
|
155,419
|
49,847
|
Named Executive Officer Compensation.
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
31,396,473
|
10,463,957
|
193,484
|
4,381,326
|
frequency of future advisory resolutions to approve Named
Executive Compensation.
Every Year
(an annual vote)
|
Every Other Year (a biennial vote)
|
Every Three Years (a triennial vote)
|
Abstentions
|
Broker Non-Votes
|
34,110,634
|
50,046
|
7,787,051
|
106,183
|
4,381,326
|
Equity Incentive Plan.
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
25,344,555
|
16,675,097
|
34,262
|
4,381,326
|
Bonus Incentive Plan.
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
41,531,637
|
439,362
|
82,915
|
4,381,326
|
About MASIMO CORPORATION (NASDAQ:MASI)
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.